Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Bridge Medicines is a groundbreaking initiative that completes anunbroken, fully funded and professionally staffed path from concept to drug candidate, to develop efficiently and quickly innovative therapeutics for the treatment of human diseases.

��

Jill Porter

Vice President Of Biologics at Bridge Medicines LLC

Org chart

Teams

Offices

Related people

Durga Prasad Ketha

Shintaro Koyama

Pawan Goenka

Erick Manuel Penaranda

Alan Smith

��������